The objectives of this analysis were : ( @ ) to evaluate the pharmacokinetics of pregabalin controlled-release ( CR ) administered with food relative to the pregabalin IR formulation administered fasted ; ( @ ) to evaluate the pharmacokinetics of a two-tablet dose of pregabalin CR compared with the equivalent one-tablet dose of pregabalin CR ; and ( @ ) to determine the safety and tolerability of multiple-dose administration of pregabalin CR and IR .